By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Tilray Brands, Inc.

Tilray Brands, Inc. (TLRY)

NASDAQ Currency in USD
$51.00
-$0.32
-0.61%
Last Update: 18 Jul 2026, 14:26
$4.54bn
Market Cap
-2.73
P/E Ratio (TTM)
Forward Dividend Yield
$38.19-$70.47
52 Week Range

TLRY Stock Price Chart

Explore Tilray Brands, Inc. interactive price chart. Choose custom timeframes to analyze TLRY price movements and trends.

TLRY Company Profile

Discover essential business fundamentals and corporate details for Tilray Brands, Inc. (TLRY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

19 Jul 2018

Employees

2.65k

CEO

Irwin David Simon

Description

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

TLRY Financial Timeline

Browse a chronological timeline of Tilray Brands, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 Jul 2026

EPS estimate is -$0.01, while revenue estimate is $249.64m.

Earnings released on 1 Apr 2026

EPS came in at -$0.24 falling short of the estimated -$0.14 by -71.43%, while revenue for the quarter reached $206.73m , beating expectations by +2.67%.

Earnings released on 8 Jan 2026

EPS came in at -$0.41 falling short of the estimated -$0.14 by -192.86%, while revenue for the quarter reached $217.51m , beating expectations by +3.11%.

Stock split effective on 2 Dec 2025

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 9 Oct 2025

EPS came in at -$0.00 surpassing the estimated -$0.27 by +98.43%, while revenue for the quarter reached $287.78m , beating expectations by +40.69%.

Earnings released on 28 Jul 2025

EPS came in at $0.02 surpassing the estimated -$0.03 by +166.67%, while revenue for the quarter reached $224.46m , beating expectations by +7.66%.

Earnings released on 8 Apr 2025

EPS came in at -$0.10 falling short of the estimated -$0.04 by -150.00%, while revenue for the quarter reached $185.78m , missing expectations by -25.60%.

Earnings released on 10 Jan 2025

EPS came in at -$0.10 falling short of the estimated -$0.04 by -150.00%, while revenue for the quarter reached $210.95m , missing expectations by -2.49%.

Earnings released on 10 Oct 2024

EPS came in at -$0.04 falling short of the estimated -$0.04 by -11.11%, while revenue for the quarter reached $200.04m , missing expectations by -8.53%.

Earnings released on 29 Jul 2024

EPS came in at -$0.04 falling short of the estimated -$0.02 by -81.82%, while revenue for the quarter reached $229.75m , beating expectations by +1.18%.

Earnings released on 9 Apr 2024

EPS came in at -$0.12 falling short of the estimated -$0.05 by -140.00%, while revenue for the quarter reached $188.30m , missing expectations by -16.40%.

Earnings released on 9 Jan 2024

EPS came in at -$0.07 falling short of the estimated -$0.06 by -11.63%, while revenue for the quarter reached $193.52m , missing expectations by -0.81%.

Earnings released on 4 Oct 2023

EPS came in at -$0.10 falling short of the estimated -$0.05 by -100.00%, while revenue for the quarter reached $176.82m , beating expectations by +1.91%.

Earnings released on 26 Jul 2023

EPS came in at -$0.15 falling short of the estimated -$0.05 by -200.00%, while revenue for the quarter reached $183.84m , beating expectations by +19.64%.

Earnings released on 10 Apr 2023

EPS came in at -$0.04 surpassing the estimated -$0.05 by +20.00%, while revenue for the quarter reached $145.50m , missing expectations by -28.13%.

Earnings released on 9 Jan 2023

EPS came in at -$0.06 falling short of the estimated -$0.05 by -20.00%, while revenue for the quarter reached $144.14m , missing expectations by -6.88%.

Earnings released on 7 Oct 2022

EPS came in at -$0.08 falling short of the estimated -$0.06 by -33.33%, while revenue for the quarter reached $153.12m , missing expectations by -1.76%.

Earnings released on 28 Jul 2022

EPS came in at -$0.34 falling short of the estimated -$0.07 by -385.71%, while revenue for the quarter reached $153.29m , beating expectations by +1.34%.

Earnings released on 6 Apr 2022

EPS came in at $0.04 surpassing the estimated -$0.08 by +150.00%, while revenue for the quarter reached $151.35m , missing expectations by -3.08%.

Earnings released on 10 Jan 2022

EPS came in at $0.03 surpassing the estimated -$0.09 by +133.33%, while revenue for the quarter reached $154.99m , missing expectations by -36.25%.

Earnings released on 7 Oct 2021

EPS came in at -$0.08 falling short of the estimated -$0.07 by -14.29%, while revenue for the quarter reached $167.94m , missing expectations by -6.35%.

Earnings released on 28 Jul 2021

EPS came in at -$0.11 falling short of the estimated -$0.08 by -37.50%, while revenue for the quarter reached $152.14m , missing expectations by -15.69%.

TLRY Stock Performance

Access detailed TLRY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run